burgeon
发表于 2025-3-21 18:25:08
书目名称Critical Issues in Head and Neck Oncology影响因子(影响力)<br> http://impactfactor.cn/2024/if/?ISSN=BK0240010<br><br> <br><br>书目名称Critical Issues in Head and Neck Oncology影响因子(影响力)学科排名<br> http://impactfactor.cn/2024/ifr/?ISSN=BK0240010<br><br> <br><br>书目名称Critical Issues in Head and Neck Oncology网络公开度<br> http://impactfactor.cn/2024/at/?ISSN=BK0240010<br><br> <br><br>书目名称Critical Issues in Head and Neck Oncology网络公开度学科排名<br> http://impactfactor.cn/2024/atr/?ISSN=BK0240010<br><br> <br><br>书目名称Critical Issues in Head and Neck Oncology被引频次<br> http://impactfactor.cn/2024/tc/?ISSN=BK0240010<br><br> <br><br>书目名称Critical Issues in Head and Neck Oncology被引频次学科排名<br> http://impactfactor.cn/2024/tcr/?ISSN=BK0240010<br><br> <br><br>书目名称Critical Issues in Head and Neck Oncology年度引用<br> http://impactfactor.cn/2024/ii/?ISSN=BK0240010<br><br> <br><br>书目名称Critical Issues in Head and Neck Oncology年度引用学科排名<br> http://impactfactor.cn/2024/iir/?ISSN=BK0240010<br><br> <br><br>书目名称Critical Issues in Head and Neck Oncology读者反馈<br> http://impactfactor.cn/2024/5y/?ISSN=BK0240010<br><br> <br><br>书目名称Critical Issues in Head and Neck Oncology读者反馈学科排名<br> http://impactfactor.cn/2024/5yr/?ISSN=BK0240010<br><br> <br><br>
鉴赏家
发表于 2025-3-21 22:26:20
http://reply.papertrans.cn/25/2401/240010/240010_2.png
木质
发表于 2025-3-22 00:46:56
Jan B. Vermorken,Volker Budach,Brian O’SullivanBrings into focus the latest advances in cancer precision medicine.Discusses medical, radiological and surgical approaches to treatment.Edited by key opinion leaders in the field.This book is open acc
Anthropoid
发表于 2025-3-22 05:39:24
http://reply.papertrans.cn/25/2401/240010/240010_4.png
声明
发表于 2025-3-22 12:35:18
http://reply.papertrans.cn/25/2401/240010/240010_5.png
鉴赏家
发表于 2025-3-22 15:25:53
http://reply.papertrans.cn/25/2401/240010/240010_6.png
鉴赏家
发表于 2025-3-22 17:45:33
http://reply.papertrans.cn/25/2401/240010/240010_7.png
诗集
发表于 2025-3-22 23:25:52
Bettina Schwörer,Gabriele Oettingenthey represent a non-invasive source of clinically exploitable biomarkers, including circulating tumor cells (CTCs) and cell-free tumor DNA (ctDNA). Assessment of CTCs in peripheral blood from solid cancer patients has proven useful for detection of subclinical disease which otherwise remains invisi
举止粗野的人
发表于 2025-3-23 03:49:06
http://reply.papertrans.cn/25/2401/240010/240010_9.png
畸形
发表于 2025-3-23 08:57:54
http://reply.papertrans.cn/25/2401/240010/240010_10.png